---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-034623"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:19:00.465965+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BiomX stockholders approve warrant exercise at special meeting

## Summary
- 16,824,049 common shares represented at special meeting on April 21, 2025.
- Proposal 1 (warrant exercise approval): 16,069,898 for, 29,372 against, 18,428 abstain, 0 broker non-votes.
- Proposal 2 (adjournment if needed): 16,784,878 for, 29,325 against, 9,846 abstain; not needed.
- Warrants were issued in private placements and inducement letter dated February 25, 2025.

## SEC filing metadata
- accession: 0001213900-25-034623
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390025034623/0001213900-25-034623-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390025034623/ea023930201-8k_biomxinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-034623
- JSON: https://secwatch.observer/filing/0001213900-25-034623.json
- Plain text: https://secwatch.observer/filing/0001213900-25-034623.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.